Finished
A Prospective, Single-center, Single-arm, Pivotal Trial of the Medtronic Hugo™ Robotic Assisted Surgery (RAS) System
NCT05715827 · Medtronic - MITG · Updated 5 Nov 2024
- What is being tested
- RAS prostatectomy and RAS cholecystectomy
- For
- Prostate Cancer; Cholelithiases; Cholecystitis; Gallbladder Polyp
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 22 years and older. About 42 people. The full rules are on the registry page.
- Where
- South Korea
- When
- Starts or started 12 Feb 2023, ends 10 July 2023. Registered 8 Feb 2023.
- Results
- Posted on the registry on 5 Nov 2024.
In the researchers' words
The goal of this clinical trial is to test the safety and effectiveness of the Medtronic Hugo™ RAS System in patients undergoing a prostatectomy or a cholecystectomy. A minimum of 40 subjects will be enrolled at single site in Republic of Korea: 20 for prostatectomy and 20 for cholecystectomy. All participants will be followed for 30 days (±7 days) post-procedure.
Sites
- Seoul National University HospitalSeoul, Jongno-gu, South Korea